U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
186451186451Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid TumorsCompletedNo Results AvailableNeuroblastoma|Sarcoma|Unspecified Childhood Solid Tumor, Protocol SpecificBiological: anti-thymocyte globulin|Drug: busulfan|Drug: cyclosporine|Drug: melphalan|Drug: methotrexate|Drug: methylprednisolone|Procedure: allogeneic bone marrow transplantation|Procedure: peripheral blood stem cell transplantation|Procedure: umbilical cord blood transplantationhttps://ClinicalTrials.gov/show/NCT00112645
186452186452Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal TumorCompletedNo Results AvailableGastrointestinal Stromal TumorDrug: imatinib mesylate|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00112632
186453186453Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid TumorsTerminatedNo Results AvailableBrain and Central Nervous System Tumors|Carcinoma of Unknown Primary|Leukemia|Lymphoma|Unspecified Childhood Solid Tumor, Protocol SpecificDrug: topotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00112619
186454186454Fludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerCompletedNo Results AvailableAccelerated Phase Chronic Myelogenous Leukemia|Acute Undifferentiated Leukemia|Adult Acute Lymphoblastic Leukemia in Remission|Adult Acute Myeloid Leukemia in Remission|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Acute Myeloid LeukemDrug: fludarabine phosphate|Radiation: total-body irradiation|Procedure: peripheral blood stem cell transplantation|Drug: cyclosporine|Drug: mycophenolate mofetil|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00112593
186455186455MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNo Results AvailablePancreatic CancerBiological: ipilimumabhttps://ClinicalTrials.gov/show/NCT00112580
186456186456Total-Body Irradiation, Thiotepa, and Fludarabine in Treating Young Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNo Results AvailableLeukemia|Myelodysplastic SyndromesDrug: fludarabine phosphate|Drug: thiotepa|Procedure: peripheral blood stem cell transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00112567
186457186457Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid LeukemiaCompletedNo Results AvailableLeukemiaDrug: cytarabine|Drug: laromustine|Other: placebohttps://ClinicalTrials.gov/show/NCT00112554
186458186458Bevacizumab, Gemcitabine, and Oxaliplatin in Treating Patients With Metastatic Pancreatic CancerCompletedNo Results AvailablePancreatic CancerBiological: bevacizumab|Drug: gemcitabine hydrochloride|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00112528
186459186459Modafinil in Treating Fatigue in Patients With CancerActive, not recruitingNo Results AvailableCognitive/Functional Effects|Depression|Fatigue|Unspecified Adult Solid Tumor, Protocol SpecificDrug: modafinil|Procedure: cognitive assessment|Procedure: psychosocial assessment and care|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00112515
186460186460Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma MultiformeCompletedNo Results AvailableBrain and Central Nervous System TumorsDrug: Celecoxib|Drug: Isotretinoin|Drug: Temozolomide|Drug: Thalidomidehttps://ClinicalTrials.gov/show/NCT00112502
186461186461Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine CancerCompletedHas ResultsSarcomaDrug: carboplatin|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00112489
186462186462Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid TumorsCompletedNo Results AvailableRecurrent Melanoma|Recurrent Renal Cell Cancer|Stage IV Melanoma|Stage IV Renal Cell Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: bryostatin 1|Drug: temsirolimushttps://ClinicalTrials.gov/show/NCT00112476
186463186463Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue SarcomaActive, not recruitingNo Results AvailableAdult Alveolar Soft-part Sarcoma|Adult Angiosarcoma|Adult Epithelioid Sarcoma|Adult Extraskeletal Chondrosarcoma|Adult Extraskeletal Osteosarcoma|Adult Fibrosarcoma|Adult Leiomyosarcoma|Adult Liposarcoma|Adult Malignant Fibrous Histiocytoma|Adult MalignanDrug: romidepsinhttps://ClinicalTrials.gov/show/NCT00112463
186464186464A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)Active, not recruitingHas ResultsOsteoporosisDrug: MK0822|Drug: MK0822|Drug: MK0822|Drug: MK0822|Dietary Supplement: Vitamin D3|Dietary Supplement: Calcium Carbonate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00112437
186465186465Trial of Cardiac Magnetic Resonance Imaging (MRI) Versus Cardiac Catheterization Prior to Glenn OperationCompletedNo Results AvailableCongenital Heart DefectsProcedure: Diagnostic cardiac MRI|Procedure: Cardiac catheterizationhttps://ClinicalTrials.gov/show/NCT00112424
186466186466Comparison of Two Bronchodilator Inhalers in Pediatric AsthmaticsCompletedNo Results AvailableAsthmaDrug: Bronchodilatorhttps://ClinicalTrials.gov/show/NCT00112411
186467186467Head Injury Retrieval TrialTerminatedNo Results AvailableHead Injuries, ClosedProcedure: Extended interventions by advanced level prehospital providershttps://ClinicalTrials.gov/show/NCT00112398
186468186468A Pilot Study of Etanercept in DermatomyositisCompletedHas ResultsDermatomyositisDrug: Etanercept|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00112385
186469186469Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)CompletedNo Results AvailableCancerDrug: Ridaforolimushttps://ClinicalTrials.gov/show/NCT00112372
186470186470International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. AeruginosaCompletedHas ResultsCystic FibrosisDrug: AZLI 75 mg three times a day (TID)|Drug: Placebo three times a day (TID)https://ClinicalTrials.gov/show/NCT00112359
186471186471Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedNo Results AvailableNon-Small-Cell Lung CarcinomaDrug: Cetuximab + platinum + gemcitabine|Drug: Platinum + Gemcitabinehttps://ClinicalTrials.gov/show/NCT00112346
186472186472Defining Central Circuits of PainCompletedNo Results AvailableDyspepsiaProcedure: fMRIhttps://ClinicalTrials.gov/show/NCT00112333
186473186473Comparison of Two Pulmonary Valve Replacement Methods to Treat Tetralogy of FallotCompletedNo Results AvailableTetralogy of Fallot|Pulmonary Valve Insufficiency|Ventricular Dysfunction, RightProcedure: PVR plus RV remodeling|Procedure: Standard PVRhttps://ClinicalTrials.gov/show/NCT00112320
186474186474Magnetic Resonance Imaging Guided Gynecologic BrachytherapyCompletedNo Results AvailableCervix Neoplasms|Uterine Neoplasms|Vaginal Neoplasms|Vulvar NeoplasmsProcedure: Brachytherapyhttps://ClinicalTrials.gov/show/NCT00112307
186475186475Study of Taxane/Carboplatin +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung CancerCompletedHas ResultsNon-Small-Cell Lung CarcinomaDrug: Paclitaxel (Taxane)|Drug: Docetaxel (Taxane)|Drug: Carboplatin|Drug: Cetuximabhttps://ClinicalTrials.gov/show/NCT00112294
186476186476A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart AttackTerminatedNo Results AvailableShock, CardiogenicDrug: Tilarginine Acetate Injection intravenous infusionhttps://ClinicalTrials.gov/show/NCT00112281
186477186477Quitlink : A Leveraging Solution to Tobacco CounselingCompletedNo Results AvailableSmokingBehavioral: QuitLink (office support system for quit line referral)https://ClinicalTrials.gov/show/NCT00112268
186478186478Partner Notification for Chlamydia in Primary CareCompletedNo Results AvailableChlamydia InfectionsBehavioral: Practice nurse-led partner notification|Behavioral: Referral to specialist genitourinary clinichttps://ClinicalTrials.gov/show/NCT00112255
186479186479Immunotherapy of Stage III/IV Melanoma PatientsCompletedNo Results AvailableMelanomaBiological: Montanide + Melan-A analogue peptide|Biological: Montanide + Melan-A analog peptide + NY-ESO-1 analog peptide + Mage10 peptide|Biological: Montanide + CpG-7909 / PF-3512676+Melan-A analog peptide + NY-ESO-1 analog peptide + Mage10 peptide|Biological: Montanide + CpG-7909/PF-3512676 + Melan-A native and analog peptides + NY-ESO-1 long peptide + Mage10 peptide|Biological: Montanide + CpG-7909/PF-3512676 + Melan-A native and analog peptides + NY-ESO-1 long peptide + Mage10 peptide + low dose IL-2https://ClinicalTrials.gov/show/NCT00112242
186480186480Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma PatientsCompletedNo Results AvailableMelanomaBiological: group 1|Biological: group 2|Biological: group 3|Biological: group 4https://ClinicalTrials.gov/show/NCT00112229

* Görseller ve İçerik tekif hakkına sahip olabilir